14-day RSI
44.38
+2.78+6.68%
03 January 2025
Summary:
Spyre Therapeutics stock 14-day relative strength index is 44.38, with the most recent change of +2.78 (+6.68%) on 03 January 2025. According to this value, SYRE stock is neither oversold nor overboughtSYRE RSI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SYRE RSI Performance
| PeriodPeriod | 14-day RSI14-day RSI | PricePrice | 50-day SMA50-day SMA | 200-day SMA200-day SMA |
|---|---|---|---|---|
| todaytoday | +6.7% | +2.1% | -0.7% | -0.2% |
| 1 m1 month | +20.4% | -10.7% | -6.7% | -2.9% |
| 3 m3 months | -11.4% | -14.2% | +4.6% | +3.1% |
| 6 m6 months | +7.2% | -6.1% | -10.8% | +23.3% |
| ytdytd | +15.8% | +7.7% | -1.3% | -0.5% |
| 1 y1 year | -34.1% | +15.9% | +99.2% | +188.7% |
| 5 y5 years | -2.7% | -87.3% | -85.4% | -83.8% |
SYRE RSI High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | 44.38 | at high | 31.41 | +41.3% |
| 3 m | 3 months | 75.46 | -41.2% | 31.41 | +41.3% |
| 6 m | 6 months | 75.46 | -41.2% | 31.41 | +41.3% |
| 1 y | 1 year | 84.96 | -47.8% | 28.70 | +54.6% |
| 3 y | 3 years | 87.91 | -49.5% | 16.44 | +169.9% |
| 5 y | 5 years | 87.91 | -49.5% | 16.44 | +169.9% |
| alltime | all time | 87.91 | -49.5% | 15.42 | +187.8% |
Spyre Therapeutics Stock RSI History
| Date | Value |
|---|---|
| 2025 | 44.38(+15.8%) |
| 2024 | 38.33(-45.8%) |
| 2023 | 70.73(+64.8%) |
| 2022 | 42.93(-13.3%) |
| 2021 | 49.49(+21.9%) |
| Date | Value |
|---|---|
| 2020 | 40.60(-7.8%) |
| 2019 | 44.03(-5.6%) |
| 2018 | 46.66(-22.4%) |
| 2017 | 60.14(+115.3%) |
| 2016 | 27.93 |
FAQ
- What is Spyre Therapeutics 14-day relative strength index?
- What is the all time high 14-day RSI for Spyre Therapeutics?
What is Spyre Therapeutics 14-day relative strength index?
The current 14-day RSI of SYRE is 44.38
What is the all time high 14-day RSI for Spyre Therapeutics?
Spyre Therapeutics all-time high 14-day relative strength index is 87.91